research use only

Methoxsalen P450 (e.g. CYP17) inhibitor

Cat.No.S1952

Methoxsalen (Xanthotoxin, NCI-C55903) is a naturally occurring photoactive substance found in the seeds of the Ammi majus (Umbelliferae) plant, used in the diagnosis and treatment of psoriasis; this compound is a CYP2A5/6 inhibitor.
Methoxsalen P450 (e.g. CYP17) inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 216.19

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 216.19 Formula

C12H8O4

Storage (From the date of receipt)
CAS No. 298-81-7 Download SDF Storage of Stock Solutions

Synonyms Xanthotoxin, NCI-C55903 Smiles COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2

Solubility

In vitro
Batch:

DMSO : 43 mg/mL ( (198.89 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 5 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
CYP2A5 [6]
CYP2A6 [6]
In vitro
Methoxsalen inhibits CYP2A6 (Ki = 0.8 μM) with about 3.5- 94-fold greater potency than other P450s, except for CYP1A2 (Ki = 0.2 μM). This compound shows noncompetitive inhibition of nicotine metabolism, with an apparent Ki value of 0.1 μM in cDNA-expressing microsomes. [1] It is metabolized in human liver microsomes at the rate of 50-100 pmol/mg protein/min (approx. 30% of the activity in mouse liver microsomes). This chemical is a very potent inhibitor of human cytochrome P450 2A6 (CYP2A6) and mouse Cyp2a-5-mediated coumarin 7-hydroxylation in vitro. [2]
In vivo
Methoxsalen results in a significant decrease in the following factors: number and diameter of corpus lutei, Graafian follicles, diameter of granulosa cell layer and oocytes, number of primordial and primary and growing follicles, while the number of atretic follicle is increased. This compound also significantly reduces circulating estrogen levels in blood serum of oogenesis Balb/C mice. [3] It dose-dependently stimulates a sustained increase in short-circuit current in the mouse jejunum. The chemical increases the open probability of the basolateral IK(Ca) channel of isolated crypts in the mouse jejunum. [4] It effectively reverses trimethyltin (TMT)-induced memory impairment on both Y-maze and passive avoidance tests in mice. This agent inhibits brain AchE activity. It significantly ameliorates the level of oxidative stress. [5]
References
  • https://pubmed.ncbi.nlm.nih.gov/12392107/
  • https://pubmed.ncbi.nlm.nih.gov/21979070/
  • https://pubmed.ncbi.nlm.nih.gov/24859605/

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04389281 Recruiting
Advanced Solid Tumor Cancer
Immunolight LLC
December 8 2021 Phase 1

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map